retatrutide glp-1 medication Some Providers Prescribe Unapproved for Weight Loss at Alarming Rate Retatrutide vs Tirzepatide (2026): Differences

Does Omzo require an in-person appointment

Call/Text us at 312.312.7873 or book your appointment online today

Heres what happened: Starting point: Weight: 89.5kg Body fat: 15% Fat mass: 13.4kg Muscle mass: 73.5kg Visceral fat: Level 5 (relatively low) After 3 months: Weight: 77kg Body fat: 8.3% Fat mass: 6.8kg Muscle mass: 71.1kg Visceral fat: Level 2 Total changes: Weight lost: 12.5kg Fat lost: 6.6kg (over a stone of pure fat) Muscle lost: 2.4kg (mostly water, not actual muscle tissue) Visceral fat reduction: 60% Cardiovascular fitness: VO2 max improved from 51 54 (significant increase) Strength: Lost 10-15% on main lifts (bench press, squats, pull-ups)

Ethics declarations Competing interests KGW and VJNB are co-founders and shareholders of Aprea Therapeutics AB, a company that develops novel p53-based cancer therapy